RxDoctor Payments Data

Gary Wang, MD

Infectious Disease · Gainesville, FLNPI 1235158759

Payments from drug & device makers

What this record shows

That places this record below the midpoint for infectious disease clinicians in FL, where the typical reported total is $652.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$450,872in research payments, 2019–2025

Across 134 payments — averaging $3364.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$288K
  • Amgen$134K
  • Ferring Pharmaceuticals AS$28K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 669 infectious disease providers in Florida.

See all infectious disease providers in Florida

Medicare billing

Part B allowed, 2024
$27,910
Medicare patients
135
Services billed
254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala48$194,395

Paid to pharmacies, not to this prescriber.

Other infectious disease in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →